Cumberland Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Cumberland Pharmaceuticals M&A Summary

Cumberland Pharmaceuticals has acquired 1 company.

Cumberland Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired Theravance Biopharma - VIBATIV for $20M. Cumberland Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Cumberland Pharmaceuticals Business Overview

Where is Cumberland Pharmaceuticals headquartered?

Cumberland Pharmaceuticals is headquartered in Nashville, Tennessee.

What is Cumberland Pharmaceuticals’ revenue?

Cumberland Pharmaceuticals disclosed revenue of 40M USD for 2023 and 42M USD for 2022.

How many employees does Cumberland Pharmaceuticals have?

Cumberland Pharmaceuticals has 91 employees.

What sector is Cumberland Pharmaceuticals in?

Cumberland Pharmaceuticals is a life science company.

When was Cumberland Pharmaceuticals founded?

Cumberland Pharmaceuticals was founded in 1999.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals, Inc.

1600 West End Avenue, Suite 1300,
Nashville, Tennessee 37203
United States,
(615) 255-0068
www.cumberlandpharma.com

Cumberland Pharmaceuticals is a pharmaceutical company that acquires and develops branded prescription products primarily in the gastroenterology, critical care and infection control areas. Cumberland Pharmaceuticals was founded in 1999 and is based in Nashville, Tennessee.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $20M $20M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Theravance Biopharma, Inc. - VIBATIV 2018-11-06 20M USD Divestiture
South San Francisco, California · www.vibativ.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 20M (100%) - -
Total 1 $20M - -

By Geo

State/Country Buy Value Sell Value
United States 1 20M - -
  California 1 20M - -
Total 1 $20M - -

Deal Values

buy # Total
< $100M 1 $20M
TOTAL $20M
Largest Theravance Biopharma, Inc. - VIBATIV
$20M (2018-11-06)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.